BioSpace News Archive

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending marketing authorization for ULTOMIRIS® (ravulizumab), the first and only long-acting C5 complement inhibitor administered every eight weeks.

OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to offer the best patient care, will host its latest State of the Science Summit™ on non-small cell lung cancer on Thursday, May 2, from 5 to 9 p.m. at the Wyndham Pittsburgh University Center in Pittsburgh, Pennsylvania.

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, is pleased to announce its Chief Science Officer, Dr. Kristin Comella, will present at the 2018 Paleo f(x) Conference Sunday, April 28, at the Palmer Events Center in Austin, Texas.

Karuna Therapeutics, Inc. announced that it has previously confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock.

Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments to address functional mitral regurgitation in patients with heart failure, presented new data confirming significant reduction in regurgitant volume directly after implantation of the Carillon Mitral Contour System® at the German Society of Cardiology annual congress, DGK 2019.

Santen Pharmaceutical Co., Ltd. and Glaukos Corporation, announced that Santen’s U.S. subsidiary, Santen Inc., has entered into a multi-year agreement whereby Glaukos will become the exclusive distributor of the MicroShunt solely in the U.S. market.

Inmediata Health Group, Corp. recently became aware of a data security incident that may have involved the limited personal and medical information of some of its customers’ patients.

Elanco announces formation of commercial team dedicated to veterinary specialty business

Establish Intellectual Property Partnership and $10 Million Strategic Equity Investment

IMV Inc. announced that it will hold a conference call and webcast on Friday, May 10, 2019 at 8:00 a.m. ET to discuss the company’s first quarter 2019 financial and operational results.